Faltering Under Pressure: Limitations to Noninvasive Diastolic Function Assessments

Código QR

Faltering Under Pressure: Limitations to Noninvasive Diastolic Function Assessments

Guardado en:

Detalles Bibliográficos
Autores principales:	James P. MacNamara, Satyam Sarma
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Editorials diastolic function heart failure with preserved ejection fraction hemodynamics Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/b57f53cafaf54646983fa0c5d9cfcc91
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A study of association between heart failure with preserved ejection fraction with hypertension and diabetes mellitus
por: Swapan Sarkar, et al.
Publicado: (2021)

Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction
por: Arno A. van de Bovenkamp, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
por: Marat Fudim, et al.
Publicado: (2021)

The Impact of Deep Y Descent on Hemodynamics in Patients With Heart Failure and Preserved Left Ventricular Systolic Function
por: Daisuke Harada, et al.
Publicado: (2021)

Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
por: Dzhioeva O, et al.
Publicado: (2020)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Steffen Pabel, et al.
Publicado: (2021)

Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy
por: Amy Hyein Kim, et al.
Publicado: (2022)

Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial
por: Carolyn S. P. Lam, et al.
Publicado: (2021)

Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis
por: Masatake Kobayashi, et al.
Publicado: (2021)

Constrictive pericarditis in the setting of repeated chest trauma in a mixed martial arts fighter
por: Meganne N. Ferrel, et al.
Publicado: (2021)

Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction
por: Wan Ting Tay, et al.
Publicado: (2021)

Systolic Blood Pressure and Outcome in Patients Admitted With Acute Heart Failure: An Analysis of Individual Patient Data From 4 Randomized Clinical Trials
por: Johannes Grand, et al.
Publicado: (2021)

Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension
por: M. A. Manukyan, et al.
Publicado: (2021)

The Prognostic Value of Lung Ultrasound in Patients With Newly Diagnosed Heart Failure With Preserved Ejection Fraction in the Ambulatory Setting
por: Blanka Morvai-Illés, et al.
Publicado: (2021)

Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction
por: Zheng,Huan, et al.
Publicado: (2014)

Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
por: Domingo Pascual-Figal, et al.
Publicado: (2021)

Clinical course and outcomes of chronic heart failure with preserved left ventricular ejection fraction in concomitant overweight and obesity with comorbid atrial fibrillation
por: P. P. Bidzilya, et al.
Publicado: (2021)

A Universal New Definition of Heart Failure With Improved Ejection Fraction for Patients With Coronary Artery Disease
por: Haozhang Huang, et al.
Publicado: (2021)

Causes and predictors of hospital readmissions in patients older than 65 years hospitalized for heart failure with preserved left ventricular ejection fraction in western Romania
por: Mavrea AM, et al.
Publicado: (2015)

Valor pronóstico de la hiperuricemia en la insuficiencia cardíaca crónica
por: Martínez S,Alejandro, et al.
Publicado: (2004)

Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis
por: Yibo He, et al.
Publicado: (2021)

Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure
por: Li-fang Ye, et al.
Publicado: (2021)

Interatrial shunt devices for heart failure with normal ejection fraction: a technology update
por: Cuthbert JJ, et al.
Publicado: (2017)

Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation
por: Silvia Oghina, et al.
Publicado: (2021)

Clinical Outcomes of Patients with Coronary Artery Diseases and Moderate Left Ventricular Dysfunction: Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery
por: Wang S, et al.
Publicado: (2021)

Comparison of Pharmacological Treatment Effects on Long-Time Outcomes in Heart Failure With Preserved Ejection Fraction: A Network Meta-analysis of Randomized Controlled Trials
por: Yaowang Lin, et al.
Publicado: (2021)

Tricuspid insufficiency after cardiac-implantable electronic device placement
por: Nismat Javed, et al.
Publicado: (2021)

Factors associated with prolonged hospitalization, readmission, and death in elderly heart failure patients in western Romania
por: Gyalai-Korpos I, et al.
Publicado: (2015)

Recent and Upcoming Drug Therapies for Pediatric Heart Failure
por: Karla L. Loss, et al.
Publicado: (2021)

Deep Learning Predicts Heart Failure With Preserved, Mid-Range, and Reduced Left Ventricular Ejection Fraction From Patient Clinical Profiles
por: Mohanad Alkhodari, et al.
Publicado: (2021)

Right Ventricular Diastolic Performance in Patients With Chronic Thromboembolic Pulmonary Hypertension Assessed by Echocardiography
por: Hong Meng, et al.
Publicado: (2021)

Vagal Neuromodulation in Chronic Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis
por: Lucas Bonacossa Sant'Anna, et al.
Publicado: (2021)

Influence of metabolic and proinflammatory factors on diastolic heart failure formation in females with essential hypertension
por: Anton V. Barsukov, et al.
Publicado: (2020)

Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction
por: Yiling Zhou, et al.
Publicado: (2021)

The Effects of Hypertension Stages on N-Terminal-Pro Brain Natriuretic Peptide (NT-Pro-BNP) Level and Left Ventricular Ejection Fraction
por: Kati Sriwiyati, et al.
Publicado: (2019)

Reduced ejection fraction heart failure – new data from multicenter studies and national registries regarding general and elderly populations: hopes and disappointments
por: Crișan S, et al.
Publicado: (2018)

Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy
por: Luis E. Echeverría, et al.
Publicado: (2021)

COMPARISON OF HEMODYNAMIC STABILITY WITH CISATRACURIUM AND ATRACURIUM IN PATIENTS WITH LOW EJECTION FRACTION UNDERGOING CORONARY ARTERY BYPASS GRAFTING
por: Mehwish Naseer, et al.
Publicado: (2020)

Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients
por: Huang YS, et al.
Publicado: (2014)

Visual versus fully automated assessment of left ventricular ejection fraction
por: Rami Mahmood Abazid, et al.
Publicado: (2018)